TP53 and neoplasm: Similarly, p53 mutations in the transactivation domain and p53 acetylation mutations severely inhibit p53 induction of apoptosis and senescence, yet exhibit a mild and delayed tumor onset (Li et al., 2012; Zhu et al., 2015).